A new patient preference study has been published in The Oncologist, providing insight into how myeloma patients rationalise treatments.
Myeloma patients in the UK are being invited to take part in a study that is testing a new questionnaire which aims to support patients and their clinicians in discussing, addressing and better recording quality of life issues that matter patients.
Leaving a gift in your Will is a great way to support causes that matter to you. Last year, we received £710,000 in donations from Wills which funded services for patients and families, as well as vital myeloma research.
Myeloma UK has launched MUK nine, the first UK-wide trial using state-of-the-art genetic techniques to ‘stratify’ treatment for so-called high-risk myeloma patients.
Patients in Scotland will now be able to access the new myeloma treatment, daratumumab (Darzalex®) on the NHS, after the Scottish Medicines Consortium (SMC) approved it for use.
Myeloma UK has been awarded a quality standard accreditation by The Helplines Partnership for the thirteenth year running.
Best friends Pete Wood and Nick Jellema took on a world record challenge at this year’s Great North Run, in support of Myeloma UK.
Hotel owner and art enthusiast Susie Suter, 48, from Crickhowell in South Wales was diagnosed back in August 2013. Susie originally thought that her pains were sports injuries but after several months of visiting her GP and taking painkillers, she was eventually diagnosed with myeloma.
A Myeloma UK Infopack for carers of myeloma patients has been Highly Commended in the 2017 British Medical Association (BMA) Patient Information Awards.
The seasonal influenza (flu) vaccination is now available from your GP practice.
It is recommended that myeloma patients are vaccinated against the seasonal flu every year. This is because each year the virus that causes flu changes and a new vaccine is developed to protect against the new type of virus.